Financhill
Sell
31

ARM Quote, Financials, Valuation and Earnings

Last price:
$132.28
Seasonality move :
82.67%
Day range:
$128.30 - $135.79
52-week range:
$65.11 - $188.75
Dividend yield:
0%
P/E ratio:
220.25x
P/S ratio:
39.53x
P/B ratio:
23.10x
Volume:
5.3M
Avg. volume:
4.9M
1-year change:
93.2%
Market cap:
$138.9B
Revenue:
$3.2B
EPS (TTM):
$0.60
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue -- $2B $2.7B $2.7B $3.2B
Revenue Growth (YoY) -- 41.3% 33.35% -0.89% 20.68%
 
Cost of Revenues -- $145M $131M $106M $154M
Gross Profit -- $1.9B $2.6B $2.6B $3.1B
Gross Profit Margin -- 92.85% 95.15% 96.04% 95.24%
 
R&D Expenses -- $814M $995M $1.1B $2B
Selling, General & Admin -- $826M $897M $762M $983M
Other Inc / (Exp) -- $453M $104M -$49M -$15M
Operating Expenses -- $1.6B $1.9B $1.9B $3B
Operating Income -- $242M $680M $678M $117M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- $697M $786M $671M $212M
Earnings of Discontinued Ops. -- -$156M -$127M -- --
Income Tax Expense -- $153M $110M $147M -$94M
Net Income to Company -- $388M $549M $524M $306M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- $388M $549M $524M $306M
 
Basic EPS (Cont. Ops) -- $0.38 $0.54 $0.51 $0.30
Diluted EPS (Cont. Ops) -- $0.38 $0.54 $0.51 $0.29
Weighted Average Basic Share -- $1B $1B $1B $1B
Weighted Average Diluted Share -- $1B $1B $1B $1B
 
EBITDA -- $443M $865M $848M $279M
EBIT -- $242M $680M $678M $117M
 
Revenue (Reported) -- $2B $2.7B $2.7B $3.2B
Operating Income (Reported) -- $242M $680M $678M $117M
Operating Income (Adjusted) -- $242M $680M $678M $117M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $630M $806M $844M
Revenue Growth (YoY) -- -- -- 27.94% 4.72%
 
Cost of Revenues -- -- $25M $46M $32M
Gross Profit -- -- $605M $760M $812M
Gross Profit Margin -- -- 96.03% 94.29% 96.21%
 
R&D Expenses -- -- $248M $626M $507M
Selling, General & Admin -- -- $172M $290M $241M
Other Inc / (Exp) -- -- -$39M $9M -$29M
Operating Expenses -- -- $420M $916M $748M
Operating Income -- -- $185M -$156M $64M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- $152M -$119M $64M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $38M -$9M -$43M
Net Income to Company -- -- $114M -$110M $107M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- $114M -$110M $107M
 
Basic EPS (Cont. Ops) -- -- $0.11 -$0.11 $0.10
Diluted EPS (Cont. Ops) -- -- $0.11 -$0.11 $0.10
Weighted Average Basic Share -- -- $1B $1B $1B
Weighted Average Diluted Share -- -- $1B $1B $1.1B
 
EBITDA -- -- $230M -$115M $108M
EBIT -- -- $185M -$156M $64M
 
Revenue (Reported) -- -- $630M $806M $844M
Operating Income (Reported) -- -- $185M -$156M $64M
Operating Income (Adjusted) -- -- $185M -$156M $64M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $2.8B $3.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $133M $142M
Gross Profit -- -- -- $2.7B $3.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $1.6B $2B
Selling, General & Admin -- -- -- $923M $977M
Other Inc / (Exp) -- -- -$51M $3M -$15M
Operating Expenses -- -- -- $2.6B $3B
Operating Income -- -- -- $152M $408M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- $241M $512M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $61M -$129M
Net Income to Company -- -- -- $180M $641M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $180M $641M
 
Basic EPS (Cont. Ops) -- -- -- $0.17 $0.61
Diluted EPS (Cont. Ops) -- -- -- $0.17 $0.60
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- $317M $575M
EBIT -- -- -- $152M $408M
 
Revenue (Reported) -- -- -- $2.8B $3.5B
Operating Income (Reported) -- -- -- $152M $408M
Operating Income (Adjusted) -- -- -- $152M $408M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $1.3B $1.5B $1.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $50M $77M $65M
Gross Profit -- -- $1.3B $1.4B $1.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $466M $963M $992M
Selling, General & Admin -- -- $325M $486M $480M
Other Inc / (Exp) -- -- -$51M $1M $1M
Operating Expenses -- -- $791M $1.4B $1.5B
Operating Income -- -- $481M -$45M $246M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- $438M $8M $308M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $99M $13M -$22M
Net Income to Company -- -- $339M -$5M $330M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- $339M -$5M $330M
 
Basic EPS (Cont. Ops) -- -- $0.33 -$0.01 $0.31
Diluted EPS (Cont. Ops) -- -- $0.33 -$0.01 $0.31
Weighted Average Basic Share -- -- $2.1B $2.1B $2.1B
Weighted Average Diluted Share -- -- $2.1B $2.1B $2.1B
 
EBITDA -- -- $568M $37M $333M
EBIT -- -- $481M -$45M $246M
 
Revenue (Reported) -- -- $1.3B $1.5B $1.8B
Operating Income (Reported) -- -- $481M -$45M $246M
Operating Income (Adjusted) -- -- $481M -$45M $246M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents -- -- $1B $1.6B $1.9B
Short Term Investments -- -- $631M $661M $1B
Accounts Receivable, Net -- -- $1.1B $999M $781M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- $167M $169M $157M
Total Current Assets -- -- $3.1B $3.5B $4.2B
 
Property Plant And Equipment -- -- $417M $391M $420M
Long-Term Investments -- -- $736M $723M $741M
Goodwill -- -- $1.6B $1.6B $1.6B
Other Intangibles -- -- $205M $138M $152M
Other Long-Term Assets -- -- $189M $202M $270M
Total Assets -- -- $6.5B $6.9B $7.9B
 
Accounts Payable -- -- $57M $82M $26M
Accrued Expenses -- -- $98M $130M $108M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $31M $28M $32M
Other Current Liabilities -- -- $76M $35M $40M
Total Current Liabilities -- -- $1.4B $1.4B $1.5B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $3B $2.8B $2.6B
 
Common Stock -- -- $2M $2M $2M
Other Common Equity Adj -- -- $399M $376M $371M
Common Equity -- -- $3.5B $4.1B $5.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- $3.5B $4.1B $5.3B
 
Total Liabilities and Equity -- -- $6.5B $6.9B $7.9B
Cash and Short Terms -- -- $1.6B $2.2B $2.9B
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- $1.4B $1.5B
Short Term Investments -- -- -- $800M $860M
Accounts Receivable, Net -- -- -- $864M $1B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $71M
Other Current Assets -- -- -- $137M --
Total Current Assets -- -- -- $3.4B $4.1B
 
Property Plant And Equipment -- -- -- $410M $523M
Long-Term Investments -- -- -- $725M $796M
Goodwill -- -- -- $1.6B $1.6B
Other Intangibles -- -- -- $147M $184M
Other Long-Term Assets -- -- -- $211M $254M
Total Assets -- -- -- $6.8B $8.1B
 
Accounts Payable -- -- -- -- $34M
Accrued Expenses -- -- -- -- $114M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $24M $34M
Other Current Liabilities -- -- -- $200M $57M
Total Current Liabilities -- -- -- $795M $899M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $2B $2.1B
 
Common Stock -- -- -- $2M $2M
Other Common Equity Adj -- -- -- $352M $410M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $4.8B $6B
 
Total Liabilities and Equity -- -- -- $6.8B $8.1B
Cash and Short Terms -- -- -- $2.2B $2.4B
Total Debt -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- $388M $549M $524M $306M
Depreciation & Amoritzation -- $201M $185M $170M $162M
Stock-Based Compensation -- $54M $26M $79M $1B
Change in Accounts Receivable -- -$12M -$377M $123M -$89M
Change in Inventories -- -- -- -- --
Cash From Operations -- $1.2B $458M $739M $1.1B
 
Capital Expenditures -- $165M $75M $93M $143M
Cash Acquisitions -- -$50M -$8M -$15M -$32M
Cash From Investing -- -$340M -$619M -$138M -$516M
 
Dividends Paid (Ex Special Dividend) -- -$750M -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $50M -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$39M -$82M -$42M -$208M
Cash From Financing -- -$789M -$32M -$42M -$208M
 
Beginning Cash (CF) -- $1.1B $1.2B $1B $1.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $104M -$193M $559M $366M
Ending Cash (CF) -- $1.2B $1B $1.6B $1.9B
 
Levered Free Cash Flow -- $1.1B $383M $646M $947M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- $114M -$110M $107M
Depreciation & Amoritzation -- -- $45M $41M $44M
Stock-Based Compensation -- -- $34M $513M $218M
Change in Accounts Receivable -- -- -$121M -$22M -$111M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- $76M $227M $6M
 
Capital Expenditures -- -- $34M $47M $60M
Cash Acquisitions -- -- -- -- -$5M
Cash From Investing -- -- -$154M -$46M $75M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$9M -$24M -$53M
Cash From Financing -- -- -$9M -$24M -$53M
 
Beginning Cash (CF) -- -- $788M $1.2B $1.5B
Foreign Exchange Rate Adjustment -- -- -$11M $1M $5M
Additions / Reductions -- -- -$87M $157M $28M
Ending Cash (CF) -- -- $690M $1.4B $1.5B
 
Levered Free Cash Flow -- -- $42M $180M -$54M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- $180M $641M
Depreciation & Amoritzation -- -- -- $165M $167M
Stock-Based Compensation -- -- $47M $685M $784M
Change in Accounts Receivable -- -- -- $341M -$513M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- $1B $693M
 
Capital Expenditures -- -- $60M $106M $168M
Cash Acquisitions -- -- -$3M -$23M -$62M
Cash From Investing -- -- -- -$243M -$292M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$61M -$318M
Cash From Financing -- -- -- -$61M -$318M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $703M $83M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- $901M $525M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- $339M -$5M $330M
Depreciation & Amoritzation -- -- $87M $82M $87M
Stock-Based Compensation -- -- $47M $653M $400M
Change in Accounts Receivable -- -- -$170M $48M -$376M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$155M $113M -$284M
 
Capital Expenditures -- -- $60M $73M $98M
Cash Acquisitions -- -- -$3M -$11M -$41M
Cash From Investing -- -- -$118M -$223M $1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$20M -$39M -$149M
Cash From Financing -- -- -$20M -$39M -$149M
 
Beginning Cash (CF) -- -- $1.8B $2.8B $3.4B
Foreign Exchange Rate Adjustment -- -- -$21M $1M $7M
Additions / Reductions -- -- -$293M -$149M -$432M
Ending Cash (CF) -- -- $1.5B $2.7B $3B
 
Levered Free Cash Flow -- -- -$215M $40M -$382M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock